A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease (GREEN MEMORY)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04520412 |
|
Recruitment Status :
Suspended
(The quality of study was seriously affected by the COVID-19, so it was decided to suspend the trial and restart it at the right time.)
First Posted : August 20, 2020
Last Update Posted : November 23, 2022
|
Sponsor:
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Information provided by (Responsible Party):
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Suspended |
|---|---|
| Estimated Primary Completion Date : | December 2025 |
| Estimated Study Completion Date : | October 2026 |